Literature DB >> 34766971

Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting Requirements.

Reshma Ramachandran1,2, Christopher J Morten3,4, Joseph S Ross1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34766971     DOI： 10.1001/jama.2021.19773

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register.

Authors:  Sarai Mirjam Keestra; Florence Rodgers; Sophie Gepp; Peter Grabitz; Till Bruckner
Journal:  Clin Trials       Date:  2022-02-16       Impact factor: 2.599

Review 2.  Alzheimer's disease drug development pipeline: 2022.

Authors:  Jeffrey Cummings; Garam Lee; Pouyan Nahed; Mina Esmail Zadeh Nojoo Kambar; Kate Zhong; Jorge Fonseca; Kazem Taghva
Journal:  Alzheimers Dement (N Y)       Date:  2022-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.